Systematic PTM knowledge extraction and evidence quality assessment in alzheimer's disease research
Active Grant Awarded
- Award ID
- R21AG104819
- Recipient
-
University Of New Mexico UEI G389MFAYJNG9
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $398,050
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date 10% complete
- Place of performance
- Albuquerque, NM 87131, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services' National Institutes of Health, through the National Institute on Aging, awarded a grant of $398,050 to the University of New Mexico (Health Sciences Center) on September 9, 2026, under the Aging Research program (CFDA 93.866) for Grant R21AG104819, "Systematic PTM Knowledge Extraction and Evidence Quality Assessment in Alzheimer's Disease Research." The project adapts the REACH and INDRA automated text-mining systems, previously applied in oncology, to Alzheimer's disease. Aim 1 extracts disease-specific post-translational modification (PTM) mechanisms, including brain region, disease stage, and experimental model context, from approximately full-text PubMed Central publications and assembles them into an ontology-grounded knowledge graph. Aim 2 develops PTMQUAL, a framework that extracts indicators of analytical rigor, reproducibility, and statistical reporting from mass spectrometry experiments, assigns confidence scores to each PTM-protein association, and integrates those scores with the Aim 1 network into a confidence-weighted map of PTM mechanisms in Alzheimer's disease. The validation strategy benchmarks extraction accuracy against 200 expert-curated PTM assertions. Obligated funding is $398,050, with the period of performance running from the September 9, 2026 award date to an ultimate completion date of August 31, 2028. Place of performance is Albuquerque, New Mexico 87131. The Aging Research program supports biomedical, social, and behavioral research on the aging process, with the National Institute on Aging's emphasis on preventing and treating Alzheimer's disease and related dementias.
Description
- Abstract
- Alzheimer's disease (ad) affects over 7 million americans, yet no disease-modifying therapies exist. Advanced proteomics has revealed that post-translational modifications (PTMS), including phosphorylation, acetylation, and ubiquitination, are critical drivers of protein aggregation and neurodegeneration in ad. However, over 10,000 PTM studies are published annually, and manual curation cannot keep pace. Critical mechanistic knowledge remains buried in unstructured text. Moreover, technical variability in mass spectrometry often obscures biologically meaningful signals, making IT difficult to distinguish robust findings from artifacts. Ad research lacks automated tools to systematically extract, evaluate, and prioritize PTM mechanisms from literature at scale. In oncology, automated text-mining systems (reach: reading and extraction of actions from chemical text; indra: integrated network and dynamical reasoning assembler) have transformed target discovery by extracting mechanistic relationships and assembling them into systems biology models. This R21 will adapt these tools for ad through two complementary aims: [aim 1] will extract ad-specific PTM mechanisms from approximately full-text publications in pubmed central, capturing critical context (brain region, disease stage, experimental model) and assembling findings into an ontology-grounded knowledge graph. [aim 2] will develop ptmqual, a framework that evaluates PTM study quality by extracting indicators of analytical rigor, reproducibility, and statistical reporting from mass spectrometry experiments. Ptmqual will assign confidence scores to each PTM-protein association, which will be integrated with the aim 1 network to produce a confidence-weighted map of PTM mechanisms in ad. [validation strategy] we will benchmark extraction accuracy against 200 expert-curated PTM assertions (target: ≥85% precision/recall) and validate ptmqual scores against methodological consensus standards. [expected outcomes] include (1) validated NLP tools for neurodegenerative disease research, (2) expert-curated benchmark datasets for community use, (3) an open-access knowledge base prioritizing ad PTM mechanisms by evidence strength, and (4) identification of 10-15 high-priority kinase/phosphatase targets where PTM dysregulation converges. Deliverables include the enhanced reach/indra system for ad, confidence-scored PTM interaction networks, the open-source ptmqual database, and a python package for automated literature mining. Our multidisciplinary team combines biomedical informatics and text mining (PI) with mass spectrometry proteomics and ad neuropathology expertise (CO-I). This high-risk/high-reward R21 addresses a critical bottleneck: synthesizing massive PTM literature into actionable hypotheses. Success will provide mechanistic insight and preliminary target validation for a subsequent R01 focused on experimental interrogation of prioritized kinases. The approach aligns with national institute on aging priorities for data-driven, reproducibility-focused research and is broadly applicable to other proteinopathies (parkinson's, huntington's disease). .
Quick answers
Who received award R21AG104819?
R21AG104819 was awarded to University Of New Mexico by National Institute on Aging (National Institutes of Health) on September 9, 2026.
How much is award R21AG104819 worth?
$398,050 has been obligated on R21AG104819.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award